Persistent URL of this record https://hdl.handle.net/1887/112303
In Collections
This item can be found in the following collections:
Baricitinib, an Oral Janus Kinase (JAK) 1/JAK2 Inhibitor, in Patients with Active Rheumatoid Arthritis (RA) and an Inadequate Response to cDMARD Therapy: Results of the Phase 3 RA-BUILD Study
- All authors
- Dougados, M.; Heijde, D. van der; Chen, Y.C.; Greenwald, M.; Drescher, E.; Liu, J.J.; Beattie, S.; Torre, I. de la; Rooney, T.; Schlichting, D.; Bono, S. de; Emery, P.; Bookman, A.
- Date
- 2016-06-30
- Journal
- Journal of Rheumatology
- Volume
- 43
- Issue
- 6
- Pages
- 1188 - 1188